Related stories
ADMA Biologics Shares Rise 25% After Higher Third-Quarter Results
ADMA Biologics reported third-quarter revenue of $141.1 million, compared with $134.2 million a year earlier. Its shares were up 25% at $13.06 in morning trading.
M impact | EARNINGS | Nov 05, 2026, 03:13 PM UTC
Cummins Cuts Full-Year Outlook as North American Pickup Demand Weakens
Cummins says weaker-than-expected North American pickup-truck demand hurt third-quarter results and is expected to persist through year-end. CEO Jennifer Rumsey made the remarks in
M impact | EARNINGS | Nov 05, 2026, 03:13 PM UTC
İş Bankası Reports Q3 Net Interest Income of 36.3 MLYR TL
Net interest income was 25.60 MLYR TL in the same period last year.
M impact | EARNINGS | Nov 05, 2026, 03:12 PM UTC
Ralph Lauren Reports 3Q 2026 Revenue of $2.19B, EPS of $4.87
The headline reports revenue of $2.19 billion and EPS of $4.87. The body describes year-over-year growth in second-quarter revenue and net income, creating a period conflict.
M impact | EARNINGS | Nov 05, 2026, 03:11 PM UTC
TC Energy Q3 Adjusted EBITDA Beats Forecast; Raises 2026 Guidance
TC Energy reported adjusted EBITDA of C$3 billion, about 4% above analyst consensus. It raised 2026 guidance and extended its 5%-7% compound annual EBITDA growth target through 203
M impact | EARNINGS | Nov 05, 2026, 03:11 PM UTC
Tapestry sobe após elevar previsões anuais e meta de recompra
Tapestry elevou suas previsões anuais e a meta de recompra de ações; suas ações dispararam.
M impact | EARNINGS | Nov 05, 2026, 03:11 PM UTC